Adherence to Aromatase Inhibitors: The Role of Partners

Abramson Cancer Center at Penn Medicine

Status: Completed

Conditions: Breast Cancer Survivors

Treatments: Other: Survey

Study type: Observational

Funder types: Other

Identifiers

NCT02753985

UPCC 15114

Details and patient eligibility

About

This is a qualitative study which explores the role that partners play in breast cancer survivors adherence to aromatase inhibitors and management of their side effects. Both patients and their partners will be interviewed (separately) in order to capture multiple perspectives. The target number of subjects is 64 (32 patients and 32 partners). The primary method of data collection will be face-to-face semi-structured interviews. These interviews will be audio-recorded.

Enrollment: 40 patients

Sex: Female

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Women and partners of women with stage I-III breast cancer who

  1. have completed primary cancer treatments (surgery, chemotherapy, radiotherapy)

  2. have experienced AI side effects

  3. live with a romantic partner.

     Exclusion Criteria: